Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab.

TitleClinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab.
Publication TypeJournal Article
Year of Publication2023
AuthorsSchreidah CM, Fahmy LM, Lapolla BA, Kwinta BD, Magro CM, Geskin LJ
JournalAm J Dermatopathol
Volume45
Issue8
Pagination572-576
Date Published2023 Aug 01
ISSN1533-0311
KeywordsAntibodies, Monoclonal, Humanized, Crohn Disease, Helicobacter pylori, Humans, Lymphoma, B-Cell, Marginal Zone, Remission Induction, Stomach Neoplasms
DOI10.1097/DAD.0000000000002470
Alternate JournalAm J Dermatopathol
PubMed ID37377200
Related Faculty: 
Cynthia M. Magro, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700